Browse Category

Stock Market Analysis News 2 December 2025 - 29 December 2025

Enbridge gets a fresh 15-to-1 “scalable risk” setup as Stock Traders Daily posts new AI signals

Enbridge gets a fresh 15-to-1 “scalable risk” setup as Stock Traders Daily posts new AI signals

NEW YORK, December 29, 2025, 10:59 ET Stock Traders Daily early on Dec. 29 published a trading-setup note on Enbridge Inc (ENB), citing an “exceptional 15.2:1” risk-reward profile for the Canadian pipeline operator’s shares. Stock Traders Daily+1 The note matters for short-term traders because it maps out entry, target and stop-loss levels — prices where a position is cut to limit losses — across long, breakout and short strategies. Stock Traders Daily Stock Traders Daily said its models also identify support and resistance levels, which traders use as potential buying and selling zones. The firm’s risk-reward ratios compare the upside
29 December 2025
Rare Metals Stocks Outlook: Silver’s Record Run, Lithium Demand Warning, and Rare Earth Supply Chains in Focus Before Monday’s Open

Rare Metals Stocks Outlook: Silver’s Record Run, Lithium Demand Warning, and Rare Earth Supply Chains in Focus Before Monday’s Open

NEW YORK, Dec. 28, 2025, 12:42 PM ET — Market Closed U.S. equity markets are closed Sunday, leaving investors in rare metals stocks—from rare earths and graphite to lithium, antimony, silver, and platinum group metals—to digest a headline-heavy stretch that reshaped the near-term setup for the next trading session. The big picture going into Monday is a push-and-pull: a powerful precious-metals surge is lifting sentiment across parts of the mining complex, while fresh signals from China’s EV ecosystem are raising new questions about battery-metal demand in early 2026. Layer on top policy and supply-chain risk—a defining feature of the “critical
Semiconductor Stocks Outlook: Memory Chip Shortage, AI Spending Debate, and What to Watch Before Monday’s Open

Semiconductor Stocks Outlook: Memory Chip Shortage, AI Spending Debate, and What to Watch Before Monday’s Open

NEW YORK, Dec. 28, 2025, 12:37 p.m. ET — Market closed. U.S. stock markets are shut for the weekend, leaving semiconductor stocks in a familiar year-end spotlight: investors are weighing bullish AI-driven demand against fresh supply-chain strain and renewed questions about how durable the “AI trade” really is. With the next regular session set for Monday, Dec. 29, chipmakers and chip-linked ETFs are likely to take their cues from Sunday night futures and any new headlines on AI infrastructure spending, memory pricing, and Big Tech capex. CME Group+1 Where semiconductor stocks left off heading into the weekend The semiconductor complex
Natural Gas Prices Rise Again as Colder Forecasts Return — What Henry Hub, LNG Exports, Storage Data and Today’s Stock Market Mood Mean for Investors

Natural Gas Prices Rise Again as Colder Forecasts Return — What Henry Hub, LNG Exports, Storage Data and Today’s Stock Market Mood Mean for Investors

New York time check: It is 1:31 p.m. ET on Friday, December 26, 2025 in New York. U.S. natural gas is back in the spotlight as winter weather risk re-enters the conversation, even while Wall Street trades in a post-holiday lull near record highs. With U.S. equity benchmarks hovering close to all-time levels and trading volumes typically thinner during the last week of the year, natural gas has become one of the more reactive “macro micro” trades: a market driven by near-term temperature models, storage withdrawals, and LNG export flows—yet increasingly shaped by bigger structural debates about global LNG supply
Intuitive Surgical (ISRG) News, Analyst Forecasts and 2026 Outlook: FDA Expansion for da Vinci SP, Wall Street Targets, and What’s Next (Dec. 25, 2025)

Intuitive Surgical (ISRG) News, Analyst Forecasts and 2026 Outlook: FDA Expansion for da Vinci SP, Wall Street Targets, and What’s Next (Dec. 25, 2025)

December 25, 2025 — Intuitive Surgical, Inc. (NASDAQ: ISRG) is ending 2025 with two storylines that rarely move in sync: fresh regulatory momentum for its single-port robotic platform and a renewed valuation debate as analysts model what the next wave of procedure growth could look like in 2026. With U.S. markets closed for Christmas Day, ISRG was last quoted around the $578 level at the December 24 close, setting the stage for the next major catalyst: Intuitive’s Q4 2025 earnings expected in late January. MarketBeat Below is a comprehensive wrap of the latest news, forecasts, and analyst analysis available as
Applied Materials (AMAT) News and 2026 Outlook on Dec. 25, 2025: Record FY2025, China Export Curbs, Dividend, and Wall Street Forecasts

Applied Materials (AMAT) News and 2026 Outlook on Dec. 25, 2025: Record FY2025, China Export Curbs, Dividend, and Wall Street Forecasts

December 25, 2025 (Thursday) — Applied Materials, Inc. is closing out the year with a familiar paradox: strong financial performance driven by AI-era semiconductor demand, paired with real policy-driven friction tied to U.S.-China export controls. With U.S. equity markets closed for Christmas Day and set to reopen Friday, December 26, investors are digesting a late-year stack of catalysts—earnings and guidance, export-rule impacts, analyst upgrades, and a fresh dividend declaration—while trying to map what “normal” looks like for semiconductor equipment in 2026. NASDAQ Trader Below is a detailed roundup of the latest news, forecasts, and analyses available as of 25.12.2025, and
Wells Fargo (WFC) News on Dec. 25, 2025: Options Clearing Expansion, Investment Banking Push, and 2026 Outlook After Asset Cap Lift

Wells Fargo (WFC) News on Dec. 25, 2025: Options Clearing Expansion, Investment Banking Push, and 2026 Outlook After Asset Cap Lift

As the U.S. banking sector heads into year-end, Wells Fargo & Company (NYSE: WFC) is closing 2025 with a noticeably different narrative than the one investors and regulators have debated for much of the past decade: less about constraint, more about growth levers, fee momentum, and capital flexibility. The shift is being driven by a cluster of late-December developments—most notably a move into options clearing, an investment-banking hiring surge that has lifted the firm’s league-table standing, and a renewed focus on efficiency as CEO Charlie Scharf signals more workforce reductions in 2026. Reuters Layered on top is Wells Fargo Investment
25 December 2025
Adobe Stock Forecast: ADBE Holds Near $354 on Dec. 24, 2025 as AI Monetization, Semrush Deal, and Valuation Debate Intensify

Adobe Stock Forecast: ADBE Holds Near $354 on Dec. 24, 2025 as AI Monetization, Semrush Deal, and Valuation Debate Intensify

December 24, 2025 — Adobe Inc. (NASDAQ: ADBE) is ending the holiday-shortened Christmas Eve session in focus, as investors weigh two competing narratives: a high-margin software leader guiding to another year of growth — and a creative franchise facing louder questions about how generative AI reshapes its moat. U.S. markets are open only briefly today, closing early at 1:00 p.m. ET, which often means thinner volumes and sharper intraday moves than usual. New York Stock Exchange+1 Adobe stock today: price action and where shares stand in 2025 Adobe shares traded around the mid-$350s on Wednesday. The stock opened at $352.21
Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

As of Sunday, December 21, 2025, Amicus Therapeutics, Inc. (NASDAQ: FOLD) is no longer trading like a “typical biotech story stock.” After BioMarin’s all-cash $14.50-per-share takeover agreement, FOLD has effectively become a deal-driven, merger-arbitrage name—meaning next week’s action is likely to hinge less on quarterly fundamentals and more on the probability, timing, and conditions of closing. SEC+1 FOLD last traded around $14.18 (near the offer price), reflecting how quickly the market repriced the shares after the announcement. Investors.com Below is the week-ahead playbook: the latest news as of 21.12.2025, what Wall Street is saying, and the specific catalysts that could
Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $4.8B Cash Buyout at $14.50 Resets the Outlook (Dec. 20, 2025)

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $4.8B Cash Buyout at $14.50 Resets the Outlook (Dec. 20, 2025)

December 20, 2025 — Amicus Therapeutics, Inc. (NASDAQ: FOLD) has abruptly shifted from a “rare-disease growth story” to a merger-arbitrage stock after BioMarin Pharmaceutical announced a definitive, all-cash acquisition valued at roughly $4.8 billion. The headline number for shareholders: $14.50 per share in cash, a premium of about 33% to Amicus’ prior close. Reuters+2BioMarin Corporate+2 On December 19, FOLD shares surged and closed at $14.18, just below the cash consideration—leaving a small spread that now reflects time to close, regulatory clearance, and deal risk rather than day-to-day biotech sentiment. Finviz+1 Below is a comprehensive roundup of the latest news, forecasts,
Real Estate Stocks Outlook for 2026: REITs, Homebuilders, and PropTech Reset After December Rate Cuts

Real Estate Stocks Outlook for 2026: REITs, Homebuilders, and PropTech Reset After December Rate Cuts

Dec. 20, 2025 — Real estate stocks are heading into 2026 with a familiar catalyst back in the driver’s seat: interest rates. After the Federal Reserve lowered the federal funds target range by 25 basis points to 3.5%–3.75% at its December meeting, investors are reassessing everything from REIT dividend durability to housing demand and refinancing risk. Federal Reserve But the story isn’t a simple “rates down, REITs up” trade. Mortgage costs remain stubbornly high by pre-2022 standards, housing affordability is still tight, and commercial real estate is navigating a split market where “prime” and “problem” properties are diverging sharply. Meanwhile,
Micron Earnings Preview: Surging Memory Chip Prices Put MU Stock in the Spotlight After Broadcom and Oracle’s AI Selloff

Micron Earnings Preview: Surging Memory Chip Prices Put MU Stock in the Spotlight After Broadcom and Oracle’s AI Selloff

December 17, 2025 — Micron Technology (NASDAQ: MU) is stepping into one of the most closely watched earnings prints in the semiconductor sector this quarter, as investors look for a clear read on two forces tugging the market in opposite directions: a powerful memory pricing upcycle and fresh anxiety about AI infrastructure spending discipline. Micron is scheduled to report its fiscal first-quarter results after the U.S. market close on Wednesday, Dec. 17, 2025, followed by an earnings conference call later the same day. Micron Technology The setup is unusually consequential. In recent sessions, the broader “AI trade” has taken hits
17 December 2025
Swiss Stock Market Week Ahead: SNB at 0%, UBS Capital-Rules Compromise, Tariff Relief, and the Key Catalysts to Watch (Dec 15–19, 2025)

Swiss Stock Market Week Ahead: SNB at 0%, UBS Capital-Rules Compromise, Tariff Relief, and the Key Catalysts to Watch (Dec 15–19, 2025)

Zurich, Dec 13, 2025 — Swiss equities head into the new week with a familiar mix of “defensive resilience” and headline-driven volatility. The Swiss Market Index (SMI) spent the past several sessions grinding lower and struggling to hold early gains, even as global markets digested a U.S. rate cut and a potentially meaningful easing of trade pressure on Swiss exporters. The setup for the Swiss stock market week ahead is unusually layered: Below is what matters most for investors watching the SMI, large-cap Swiss defensives, and Switzerland’s globally exposed cyclicals in the week ahead. Where the SMI stands after a
13 December 2025
Tesla Stock (TSLA) in December 2025: Robotaxis, EV Slowdown and Price Targets to 2030

Tesla Stock (TSLA) in December 2025: Robotaxis, EV Slowdown and Price Targets to 2030

Updated: December 11, 2025 – For information only, not investment advice. Tesla stock today: price, performance and valuation Tesla, Inc. (NASDAQ: TSLA) is trading around $451 per share as of mid‑day on December 11, 2025, giving the company a market capitalization of roughly $1.5 trillion.StockAnalysis That makes Tesla one of the ten most valuable listed companies in the world.CompaniesMarketCap Over the past six months, Tesla stock is up about 38%, and roughly 13% over the last year, according to 24/7 Wall St., which notes that TSLA has outperformed the S&P 500 over that period but lagged the tech‑heavy Nasdaq.24/7 Wall
IREN Limited (IREN) Stock Forecast 2025: Can Microsoft’s $9.7B AI Cloud Deal Offset Massive Dilution Risk?

IREN Limited (IREN) Stock Forecast 2025: Can Microsoft’s $9.7B AI Cloud Deal Offset Massive Dilution Risk?

December 10, 2025 IREN Ltd (NASDAQ: IREN), the company formerly known as Iris Energy, has morphed from a niche Bitcoin miner into one of the most talked‑about AI data center plays on the market. Its share price has more than tripled over the past year, boosted by a headline‑grabbing $9.7 billion AI cloud contract with Microsoft and a wave of speculative interest.Simply Wall St+1 At the same time, IREN has loaded up on convertible debt and equity raises totaling roughly $2.3 billion, sparking fierce debate about dilution, sustainability, and whether the stock’s meteoric run can continue.AInvest+1 This article pulls together
Dyne Therapeutics Stock Soars on Duchenne Trial Data: What December 8 Means for DYN Investors

Dyne Therapeutics Stock Soars on Duchenne Trial Data: What December 8 Means for DYN Investors

Published: December 8, 2025 Dyne Therapeutics (NASDAQ: DYN) is back on biotech investors’ radar after releasing highly anticipated topline data from its Phase 1/2 DELIVER trial in Duchenne muscular dystrophy (DMD), sending the stock sharply higher on Monday. By mid‑afternoon on December 8, Dyne shares were trading around $23.20, up roughly 14% on the day, after opening at $21.59 and touching an intraday high near $25.68. The move caps a volatile year in which the stock has already seen multiple double‑digit swings tied to trial updates, analyst calls, and sector M&A. Below is a breakdown of what changed today, how
8 December 2025
Best Crypto US Stocks to Buy in December 2025: Top Miners, Exchanges and Bitcoin Treasury Plays

Best Crypto US Stocks to Buy in December 2025: Top Miners, Exchanges and Bitcoin Treasury Plays

Updated: December 7, 2025 After a euphoric run to new all‑time highs above $126,000 in October, Bitcoin has spent late 2025 in a sharp drawdown, trading closer to the mid‑$80,000–$90,000 range. ETF investors pulled a record $3.79 billion from US spot bitcoin ETFs in November as BTC fell roughly 33% from its peak, raising fresh “crypto winter 2.0” fears. 24/7 Wall St. Yet analysts from Coinbase Institutional and others argue this looks more like a mid‑cycle reset than a repeat of 2022, pointing to still‑strong institutional adoption and the prospect of Federal Reserve rate cuts on December 10. Coinbase+1 In this volatile backdrop, crypto‑linked US stocks
Waaree Energies & Waaree Renewable Technologies in Focus: RSI Divergence, 288 MW US Order and ‘Hold’ Downgrade Shape the Story on 5 December 2025

Waaree Energies & Waaree Renewable Technologies in Focus: RSI Divergence, 288 MW US Order and ‘Hold’ Downgrade Shape the Story on 5 December 2025

Mumbai / New Delhi – December 5, 2025 Waaree Energies Ltd and its listed subsidiary Waaree Renewable Technologies Ltd (WAAREERTL) are back at the centre of investor attention today as a flurry of fresh news, analyst views and technical signals converge on the same date. On 5 December 2025, investors are digesting: Together, these moves are pushing “Waaree Energies share” and “Waaree Renewable Technologies” up the Google Trends charts, as retail and institutional investors alike look for clarity on where the stock duo goes next.LatestLY+1 Why Waaree Is Trending on Google Today Google Trends data for 5 December 2025 shows
National Australia Bank (ASX:NAB) Share Price on 5 December 2025: Dividend Yield, FY25 Results and Stock Forecast

National Australia Bank (ASX:NAB) Share Price on 5 December 2025: Dividend Yield, FY25 Results and Stock Forecast

National Australia Bank Limited (ASX:NAB) shares are trading around A$40.6–A$40.7 on Friday, 5 December 2025, nudging higher after a volatile November as investors weigh a solid dividend stream against slower profit growth and a richer valuation multiple. StockAnalysis+1 According to live market data, NAB was recently quoted at A$40.64, up about 0.3–0.4% on the day, with an intraday range of A$40.28 to A$40.77 and a 52‑week range of A$31.13 to A$45.25. StockAnalysis+1 On a trailing 12‑month basis, the bank has generated roughly 14% year‑to‑date and about 9% one‑year total return including dividends, based on Yahoo Finance figures. Yahoo Finance At
Yellow Cake Plc (LON:YCA): Uranium Price Proxy With Double‑Digit Upside? Latest News, Analyst Targets and 2026 Outlook

Yellow Cake Plc (LON:YCA): Uranium Price Proxy With Double‑Digit Upside? Latest News, Analyst Targets and 2026 Outlook

Updated 2 December 2025 Yellow Cake Plc has quietly become one of the purest listed ways to bet on the uranium price. The Jersey‑incorporated vehicle doesn’t mine or process uranium; it simply buys and stores uranium oxide (U₃O₈) and lets the commodity do the talking. MarketBeat+1 As uranium prices hover near multi‑year highs and governments push nuclear power back into the energy mix, investor interest in Yellow Cake (ticker YCA in London, YLLXF over‑the‑counter in the US) has picked up again. Below is a detailed look at the latest share price, Q3 numbers, analyst forecasts, and the key risks around

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Go toTop